These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 9355344)

  • 41. Indications for dual-chamber cardioverter defibrillators at implant and at 1 year follow-up: a retrospective analysis in the single-chamber defibrillator era.
    Proclemer A; Della Bella P; Facchin D; Fattore L; Carbucicchio C; Tondo C; Lunati M; Vecchi MR; Petz E; Zecchin M
    Europace; 2001 Apr; 3(2):132-5. PubMed ID: 11333050
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Electrical storm in the ICD era.
    Jordaens LJ; Mekel JM
    Europace; 2005 Mar; 7(2):181-3. PubMed ID: 15763535
    [No Abstract]   [Full Text] [Related]  

  • 43. Heart failure devices: implantable cardioverter-defibrillators and biventricular pacing therapy.
    Kadish A; Mehra M
    Circulation; 2005 Jun; 111(24):3327-35. PubMed ID: 15967863
    [No Abstract]   [Full Text] [Related]  

  • 44. All patients with hemodynamically tolerated postinfarction ventricular tachycardia do not require an implantable cardioverter-defibrillator.
    Almendral J; Josephson ME
    Circulation; 2007 Sep; 116(10):1204-12. PubMed ID: 17768304
    [No Abstract]   [Full Text] [Related]  

  • 45. Effect of first ventricular tachycardia cycle length on rate of ventricular arrhythmia recurrence in patients with implantable cardioverter-defibrillator.
    Arya A; Haghjoo M; Nikoo MH; Dehghani MR; Fazelifar AF; Sadr-Ameli MA
    J Electrocardiol; 2006 Oct; 39(4):404-8. PubMed ID: 16895771
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Is defibrillation testing of ICDs necessary?
    Sturdivant JL; Gold MR
    Nat Rev Cardiol; 2012 Nov; 9(11):618-9. PubMed ID: 23026864
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Mortality reduction by implantable cardioverter-defibrillators in high-risk patients with heart failure, ischemic heart disease, and new-onset ventricular arrhythmia: an effectiveness study.
    Chan PS; Hayward RA
    J Am Coll Cardiol; 2005 May; 45(9):1474-81. PubMed ID: 15862422
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [The benefits of the implantable cardioverter-defibrillator in comparisons with anti-arrhythmia agents in patients surviving malignant ventricular tachyarrhythmias: a subanalysis of the AVID study by varying degrees of left ventricular dysfunction. Antiarrhythmic versus Implantable Defibrillators].
    Occhetta E
    Ital Heart J Suppl; 2000 Apr; 1(4):577-8. PubMed ID: 10832149
    [No Abstract]   [Full Text] [Related]  

  • 49. Achieving sufficient safety margins with fixed duration waveforms and the use of multiple time constants.
    Keane D; Aweh N; Hynes B; Sheahan RG; Cripps T; Bashir Y; Zaidi A; Fahy G; Lowe M; Doherty P; Kroll MK
    Pacing Clin Electrophysiol; 2007 May; 30(5):596-602. PubMed ID: 17461867
    [TBL] [Abstract][Full Text] [Related]  

  • 50. [Automatic implantable defibrillators].
    Licourt J; Orvin MA
    Soins; 2003 Jan; Spec No 1(1):12-5. PubMed ID: 12621698
    [No Abstract]   [Full Text] [Related]  

  • 51. Novel ICD therapy begets novel ICD detection: first look at the performance of the subcutaneous ICD discrimination algorithm.
    Poole JE
    Heart Rhythm; 2014 Aug; 11(8):1359-60. PubMed ID: 24815524
    [No Abstract]   [Full Text] [Related]  

  • 52. Caring for patients with implantable cardioverter defibrillators.
    Moser SA; Crawford D; Thomas A
    Crit Care Nurse; 1988; 8(2):52, 54, 56 passim. PubMed ID: 3269313
    [No Abstract]   [Full Text] [Related]  

  • 53. Case study: implications of the recommendation to the patient with an AICD to avoid magnetic fields.
    Miller K
    Am J Crit Care; 1993 Sep; 2(5):426-7. PubMed ID: 8220675
    [No Abstract]   [Full Text] [Related]  

  • 54. Ranolazine in Patients With Implantable Cardioverter-Defibrillators: Ready for Prime Time?
    Albert CM
    J Am Coll Cardiol; 2018 Aug; 72(6):646-649. PubMed ID: 30071994
    [No Abstract]   [Full Text] [Related]  

  • 55. A literature review: Advance directives and patients with implantable cardioverter defibrillators.
    Conelius J
    J Am Acad Nurse Pract; 2010 May; 22(5):250-5. PubMed ID: 20500739
    [TBL] [Abstract][Full Text] [Related]  

  • 56. A Near-Disaster in Rescuing Wide Complex Tachycardia-Can We Always Trust External Defibrillators?
    Ali Amghaiab I; Abozguia K; Ali FI
    JAMA Intern Med; 2018 Jul; 178(7):980-981. PubMed ID: 29801059
    [No Abstract]   [Full Text] [Related]  

  • 57. Outcome criteria for patients with implantable defibrillators.
    Nichols SK; Wolverton CL
    Dimens Crit Care Nurs; 1991; 10(5):294-304. PubMed ID: 1893827
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Deactivating implantable cardioverter defibrillators.
    Beattie JM; Connolly MJ; Ellershaw JE
    Ann Intern Med; 2005 Nov; 143(9):690-1; author reply 691. PubMed ID: 16263894
    [No Abstract]   [Full Text] [Related]  

  • 59. Safe MRI in Patients With an Upgraded (Conditional) Implantable Cardioverter-Defibrillator: The Beneficial Tip of a Troublesome Iceberg.
    Moss AJ; Kutyifa V
    J Am Coll Cardiol; 2015 Jun; 65(24):2589-2590. PubMed ID: 25982015
    [No Abstract]   [Full Text] [Related]  

  • 60. [Reuse of previously implanted defibrillators].
    Wolfhard U
    Versicherungsmedizin; 1996 Dec; 48(6):212-4. PubMed ID: 9082646
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.